Large fibre, small fibre and autonomic neuropathy in adolescents with type 1 diabetes: A systematic review

J Diabetes Complications. 2021 Nov;35(11):108027. doi: 10.1016/j.jdiacomp.2021.108027. Epub 2021 Aug 18.

Abstract

Aims: To estimate the prevalence of neuropathy in adolescents with type 1 diabetes.

Methods: Systematic collection of published studies exploring the prevalence of large fibre neuropathy (LFN), small fibre neuropathy (SFN), and autonomic neuropathy in adolescents with type 1 diabetes. Following prospective registration (Prospero CRD42020206093), PubMed, EMBASE, and Cochrane Library were searched for studies from 2000 to 2020. PICO framework was used in the selection process (Population: adolescents aged 10-19 years with type 1 diabetes; Intervention: diagnostic methods for neuropathy; Comparison: reference data; Outcome: data on prevalence or comparison). Data were extracted concerning study quality based on available data and established methods for determining and diagnosing various neuropathy types.

Results: From 2,017 initial citations, 27 studies (7589 participants) fulfilled eligibility criteria. The study population (47% males) had a diabetes duration between 4.0 and 10.6 years, and HbA1c level between 7.3 and 10.8%, 56-95 mmol/mol. The prevalence of LFN, based on nerve conduction studies, was 10-57%. Based on other tests for neuropathy, the prevalence of LFN and SFN was 12-62%, and that of cardiac autonomic neuropathy was 12-75%.

Conclusion: The described prevalence of neuropathy in adolescents with type 1 diabetes varied, which can be methodological due to different screening methods and classifications of neuropathy.

Keywords: Adolescents; Neuropathy; Type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Adolescent
  • Diabetes Mellitus, Type 1* / epidemiology
  • Diabetic Neuropathies / diagnosis
  • Diabetic Neuropathies / epidemiology*
  • Female
  • Humans
  • Male
  • Peripheral Nervous System Diseases* / diagnosis
  • Peripheral Nervous System Diseases* / epidemiology
  • Prevalence
  • Prospective Studies